PCVX Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Zacks Investment Research - Mentions: PFE MRNA NVAX BNTX

Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules

a month ago - By: Vaxcyte, Inc.

Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study

a month ago - By: Vaxcyte, Inc.

Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study

2 months ago - By: Benzinga - Mentions: TMO

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

2 months ago - By: Vaxcyte, Inc.

Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services

2 months ago - By: Vaxcyte, Inc.

Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services

3 months ago - By: Benzinga - Mentions: MRK PFE

Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data

3 months ago - By: Vaxcyte, Inc.

Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose

3 months ago - By: Vaxcyte, Inc.

Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose

4 months ago - By: The Motley Fool

Vaxcyte (PCVX) Q2 Loss Widens 11%

4 months ago - By: Vaxcyte, Inc.

Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV)

4 months ago - By: Yahoo Finance - Mentions: PFE

Vaxcyte, Inc. (PCVX)’s VAX-24 Achieves Phase 2 Success in Infants

5 months ago - By: Yahoo Finance - Mentions: CVX PFE MRK

Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX)

5 months ago - By: Yahoo Finance

Here’s Why Vaxcyte (PCVX) Sold Off in Q1

6 months ago - By: Yahoo Finance - Mentions: CVX

Here’s Why Vaxcyte (PCVX) Sold Off in Q1

7 months ago - By: Vaxcyte, Inc.

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

7 months ago - By: Vaxcyte, Inc.

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

7 months ago - By: Vaxcyte, Inc.

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

7 months ago - By: Vaxcyte, Inc.

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

8 months ago - By: Yahoo Finance - Mentions: APP BRBR LW

Vaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside Potential

8 months ago - By: Yahoo Finance - Mentions: LW BAC BRBR AAPL ...

Lamb Weston Holdings (LW): Among the Best Packaged Food Stocks to Buy Now

8 months ago - By: Yahoo Finance - Mentions: BRBR LLY AMZN OXY ...

Why BellRing Brands (BRBR) Is Among the Best Packaged Food Stocks to Buy Now

8 months ago - By: Yahoo Finance - Mentions: BMY HALO BAC CME ...

Is Bristol-Myers Squibb Company (BMY) One of the Best Medical Stocks to Buy According to Billionaires?

8 months ago - By: Yahoo Finance - Mentions: DHI CMG TSLA ZIP

Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI

8 months ago - By: Yahoo Finance - Mentions: TSLA NYT MS RY ...

Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz

8 months ago - By: Zacks Investment Research - Mentions: MRNA NVAX SRPT CRSP

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.

8 months ago - By: Yahoo Finance - Mentions: COIN CORZ CORT IRWD ...

VAXCYTE INC (PCVX) Stock News

PCVX Latest News, Press Relases and Analysis

Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules

Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study

Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services

Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services

Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data

Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose

Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose

Vaxcyte (PCVX) Q2 Loss Widens 11%

Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV)

Vaxcyte, Inc. (PCVX)’s VAX-24 Achieves Phase 2 Success in Infants

Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX)

Here’s Why Vaxcyte (PCVX) Sold Off in Q1

Here’s Why Vaxcyte (PCVX) Sold Off in Q1

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

Vaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside Potential

Lamb Weston Holdings (LW): Among the Best Packaged Food Stocks to Buy Now

Why BellRing Brands (BRBR) Is Among the Best Packaged Food Stocks to Buy Now

Is Bristol-Myers Squibb Company (BMY) One of the Best Medical Stocks to Buy According to Billionaires?

Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI

Rocket acquires Mr. Cooper, Musk’s xAI acquires X: Morning Buzz

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.

Coinbase Shares Head for Worst Quarter Since FTX Collapse as Crypto Slumps